Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KEMPER CorpKMPR · Entity 719 | Director | August 10, 2026 | August 11, 2026 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Director · CHIEF EXECUTIVE OFFICER | March 19, 2024 | March 20, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KEMPER Corp
Report date August 10, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,802 |
Reported balance
After 2026-08-10 transaction · row 1
1 source rowRow 1 · 2026-08-10 · Purchase · Acquired 5,000 · Balance 31,802 |
Teladoc Health, Inc.
Report date March 19, 2024 · Filed March 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 197,728 |
Reported balance
After 2024-03-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-19 · Grant · Acquired 197,728 · Balance 197,728 F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2019 Filed Mar 6, 2019 23:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 50,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · derivative · entry 7 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,333 Underlying: Common Stock · 50,333 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 4, 2020. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 13,281 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · derivative · entry 6 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,561 Underlying: Common Stock · 13,281 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 39,842 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 39,842 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Tax withholdingCommon Stock | 13,060 | $67.55 | $882,203.00 |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617,884 F2 · shares: Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantCommon Stock | 13,944 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 630,944 F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 23:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 13,281 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-003459 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,844 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-19-002220 · edgar.xml · derivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,361 Underlying: Common Stock · 1,844 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2015 The remainder of the shares vested or will vest in 30 equal monthly installments thereafter. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 28,156 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-19-002220 · edgar.xml · derivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,156 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 30,000 | $69.68 | $2,090,400.00 |
DisclosureSEC source: 0001179110-19-002220 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,719 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F2 · price: Represents the weighted average price of transactions ranging from $68.96 to $70.01. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,844 | $1.67 | $3,079.48 |
DisclosureSEC source: 0001179110-19-002220 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 633,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 28,156 | $1.07 | $30,126.92 |
DisclosureSEC source: 0001179110-19-002220 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-19-000877 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,156 Underlying: Common Stock · 30,000 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 30,000 | $63.04 | $1,891,200.00 |
DisclosureSEC source: 0001179110-19-000877 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,719 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F2 · price: Represents the weighted average price of transactions ranging from $61.56 to $64.22. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 30,000 | $1.07 | $32,100.00 |
DisclosureSEC source: 0001179110-19-000877 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 633,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 33,276 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · derivative · entry 11 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,243 Underlying: Common Stock · 33,276 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,988 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · derivative · entry 10 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,618 Underlying: Common Stock · 9,988 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2016. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 22,401 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · derivative · entry 9 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,205 Underlying: Common Stock · 22,401 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2015 The remainder of the shares vested or will vest in 30 equal monthly installments thereafter. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 31,870 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · derivative · entry 8 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,156 Underlying: Common Stock · 31,870 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 33,276 | $6.01 | $199,988.76 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · nonDerivative · entry 6 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,988 | $1.67 | $16,679.96 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · nonDerivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 22,401 | $1.67 | $37,409.67 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · nonDerivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 31,870 | $1.07 | $34,100.90 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 538,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2018 Filed Dec 21, 2018 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · derivative · entry 7 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,026 Underlying: Common Stock · 30,000 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| December 19, 2018 Filed Dec 21, 2018 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 30,000 | $49.55 | $1,486,500.00 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,184 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F2 · price: Represents the weighted average price of transactions ranging from $49.26 to $50.24. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 19, 2018 Filed Dec 21, 2018 21:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 30,000 | $1.07 | $32,100.00 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-18-013072 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,026 Underlying: Common Stock · 30,000 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 35,000 | $54.80 | $1,918,000.00 |
DisclosureSEC source: 0001179110-18-013072 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,184 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F2 · price: Represents the weighted average price of transactions ranging from $53.30 to $58.76. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 30,000 | $1.07 | $32,100.00 |
DisclosureSEC source: 0001179110-18-013072 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 541,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 25,000 | $70.29 | $1,757,250.00 |
DisclosureSEC source: 0001179110-18-012273 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,184 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F2 · price: Represents the weighted average price of transactions ranging from $68.94 to $71.87. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:04 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 25,000 | $75.05 | $1,876,250.00 |
DisclosureSEC source: 0001179110-18-011491 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,184 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F2 · price: Represents the weighted average price of transactions ranging from $73.85 to $77.20. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 16, 2018 Filed Aug 17, 2018 19:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 25,000 | $71.66 | $1,791,500.00 |
DisclosureSEC source: 0001179110-18-010663 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,184 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F2 · price: Represents the weighted average price of transactions ranging from $70.45 to $72.90. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 25,000 | $66.11 | $1,652,750.00 |
DisclosureSEC source: 0001179110-18-009811 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 586,184 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F2 · price: Represents the weighted average price of transactions ranging from $65.45 to $67.10. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 20:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 25,000 | $60.21 | $1,505,250.00 |
DisclosureSEC source: 0001179110-18-008768 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 611,184 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F1 · price: Represents the weighted average price of transactions ranging from $58.85 to $61.45. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 15, 2018 Filed May 17, 2018 21:59 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 25,000 | $48.93 | $1,223,250.00 |
DisclosureSEC source: 0001179110-18-007063 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636,184 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F1 · price: Represents the weighted average price of transactions ranging from $48.00 to $49.60. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares [purchased/ sold] at each separate price. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 19:58 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 25,000 | $41.36 | $1,034,000.00 |
DisclosureSEC source: 0001179110-18-005730 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 661,184 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F1 · price: Represents the weighted average price of transactions ranging from $40.80 to $41.80. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 40,000 | $43.27 | $1,730,800.00 |
DisclosureSEC source: 0001179110-18-004289 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 686,184 F1 · price: Represents the weighted average price of transactions ranging from $43.00 to $43.55. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 20:30 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-003850 · edgar.xml · derivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 50,000 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. F2 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 50,000 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 20:30 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-003850 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 726,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to common stock on a one-for-one basis. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 00:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-003539 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713,684 Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 39,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-003539 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,842 Underlying: Common Stock · 39,842 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning March 1, 2019. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning March 1, 2019. Read SEC document |
| March 01, 2018 Filed Mar 6, 2018 00:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 169,893 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-18-003539 · edgar.xml · derivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,893 Underlying: Common Stock · 169,893 shares Expires 2028-03-01 F1 · derivative.exercise_date: The option will vest as to 25% of the shares on March 1, 2019. The remainder of the shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| December 27, 2017 Filed Jan 16, 2018 23:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 3,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-000890 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 713,934 Read SEC document |
| December 08, 2017 Filed Jan 16, 2018 23:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 607 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-000890 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 717,654 Read SEC document |
| December 04, 2017 Filed Dec 4, 2017 22:22 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 100,000 | $32.99 | $3,299,000.00 |
DisclosureSEC source: 0001104659-17-071717 · a4.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 718,261 Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 23:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-17-013787 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,026 Underlying: Common Stock · 20,000 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 23:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 20,000 | $32.10 | $642,000.00 |
DisclosureSEC source: 0001179110-17-013787 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 818,261 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 17, 2017. F2 · price: Represents the weighted average price of transactions ranging from $30.70 to $34.15. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 23:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 20,000 | $1.07 | $21,400.00 |
DisclosureSEC source: 0001179110-17-013787 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 838,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-17-013083 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,026 Underlying: Common Stock · 20,000 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 20,000 | $33.47 | $669,400.00 |
DisclosureSEC source: 0001179110-17-013083 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 818,261 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 17, 2017. F2 · price: Represents the weighted average price of transactions ranging from $33.05 to $34.10. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 20,000 | $1.07 | $21,400.00 |
DisclosureSEC source: 0001179110-17-013083 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 838,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2017 Filed Jun 7, 2017 23:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,602 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-17-008717 · edgar.xml · derivative · entry 6 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,036 Underlying: Common Stock · 6,602 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.